Researchers discover new way to improve the subcutaneous administration of mRNA
If not before, then certainly since the first messenger RNA (mRNA) vaccines to combat the SARS CoV2 virus were approved in Germany, mRNA has become a recognized term even outside scientific circles.
What is less well known is that mRNA can be used to produce much more than just vaccines. Around 50 different procedures for the treatment of diseases including cancer are already being studied in clinical trials.
Scientists from the pharmaceutical company AstraZeneca, with the support of neutron researchers from Forschungszentrum Jülich, have now discovered how the subcutaneous administration of mRNA can be improved. The goal is for chronically ill patients to be able to self-administer the medication on a regular basis.
“This is a great discovery!” said ESO team member Themiya Nanayakkara in fall of 2018 about the discovery that almost all of the sky is invisibly glowing with Lyman-alpha emission from the early Universe. “Next time you look at the moonless night sky and see the stars, imagine the unseen glow of hydrogen: the first building block of the universe, illuminating the whole night sky.”
Lyman-alpha Emission –“
First Building Block of the Universe”
An unexpected abundance of Lyman-alpha emission that covers nearly the entire field of view in the Hubble Ultra Deep Field (HUDF) region was discovered by an international team of astronomers using the MUSE instrument on ESO’s Very Large Telescope (VLT).